Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD14 antibody

This anti-CD14 antibody is a Mouse Monoclonal antibody detecting CD14 in FACS and InhA. Suitable for Human. This Primary Antibody has been cited in 2+ publications.
Catalog No. ABIN2192076

Quick Overview for CD14 antibody (ABIN2192076)

Target

See all CD14 Antibodies
CD14

Reactivity

  • 314
  • 44
  • 36
  • 24
  • 23
  • 23
  • 22
  • 22
  • 21
  • 17
  • 15
  • 15
  • 14
  • 13
  • 12
  • 9
  • 7
  • 7
  • 6
  • 4
  • 4
  • 2
  • 1
  • 1
Human

Host

  • 270
  • 79
  • 16
  • 4
  • 3
  • 1
  • 1
  • 1
Mouse

Clonality

  • 296
  • 76
  • 2
Monoclonal

Conjugate

  • 176
  • 32
  • 28
  • 18
  • 13
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD14 antibody is un-conjugated

Application

  • 233
  • 166
  • 144
  • 77
  • 72
  • 51
  • 50
  • 45
  • 19
  • 14
  • 11
  • 7
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Inhibition Assay (InhA)

Clone

18D11
  • Sterility

    0.2 μm filtered
  • Application Notes

    For flow cytometry dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For inhibition of biological activity in vitro dilutions have to be made according to the amounts of human sCD14 to be inactivated.

    Restrictions

    For Research Use only
  • Buffer

    PBS, containing 0.1 % bovine serum albumin.

    Storage

    4 °C

    Storage Comment

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

    Expiry Date

    12 months
  • Tunheim, Schjetne, Fredriksen, Sandlie, Bogen: "Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes." in: Journal of leukocyte biology, Vol. 77, Issue 3, pp. 303-10, (2005) (PubMed).

    Wang, Jørgensen, Ellingsen, Almiöf, Thiemermann, Foster, Aasen, Solberg: "Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood." in: Shock (Augusta, Ga.), Vol. 16, Issue 3, pp. 178-82, (2001) (PubMed).

  • Target

    CD14

    Alternative Name

    CD14

    Background

    The monoclonal antibody 18D11 recognizes human monocyte marker CD14, a 53 kDa glycoprotein. CD14 is a glycophosphatidylinositol-linked protein, which is part of the LPS receptor complex. CD14 binds lipopolysaccharide (LPS) and as such, acts as a pattern recognition receptor (PRR). CD14 has also been suggested to mediate phagocytosis of bacteria an apoptotic cells. CD14 is involved in the endotoxin mediated release of Tumor Necrosis Factor-alpha by monocytic cells. CD14 is present on most monocytic and macrophage like cell types: monocytes, macrophages, Kupffer cells, pleural phagocytic cells and dendritic reticular cells. CD14 is present at low density on a subpopulation granulocytes and activated or transformed B-cells. The monoclonal antibody 18D11 reacts with both soluble and membrane CD14. The monoclonal antibody 18D11 is useful for inhibition of biological activity of sCD14, it inhibits LPS induced TNF production. The monoclonal antibody is cross reactive with pig CD14. Together with a C5a neutralizing monoclonal antibody, 18D11 blocks sepsis in a pig model.

    Pathways

    TLR Signaling, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
You are here:
Chat with us!